Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04985721
Title A Trial of Pamiparib With Tislelizumab in Patients With Advanced Tumours With Homologous Recombination Repair Defects (IMPARP-HRD)
Acronym IMPARP-HRD
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Peter MacCallum Cancer Centre, Australia
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS

Facility Status City State Zip Country Details
St Vincent's Hospital RECRUITING Fitzroy Victoria 3065 Australia Details
Austin Hospital RECRUITING Heidelberg Victoria 3084 Australia Details
Peter MacCallum Cancer Centre RECRUITING Melbourne Victoria 3000 Australia Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field